# Axay Parth MD – FDA Inspection, Oct 8, 2025

Source: https://www.keypedia.com/records/fda_inspections/axay-parth-md/c1a90c9a-e4b0-4fde-8b67-4a157ca9bfae
Source feed: FDA_Inspections

> FDA inspection 1290856 of Axay Parth MD, October 08, 2025. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1290856
- Company Name: Axay Parth MD
- Inspection Date: 2025-10-08
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1209476 - 2023-05-19

## Related Officers

- [Brandy D. Brown](https://www.keypedia.com/people/brandy-d-brown/667c6b9a-6ab9-42d4-b364-a96207bca072)
- [Company Rep](https://www.keypedia.com/people/gene-r-gunn/3c011052-9264-461e-a92e-4af3cc26819c)

Company: https://www.keypedia.com/companies/axay-parth-md/b83b92a5-8a3d-423c-9bd1-7b9df6fbc02b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c